The Elizabeth Holmes Trial: Former Schering-Plough Scientist Cites Theranos Founder’s ‘Cagey’ Behavior

For the second time since the trial of Elizabeth Holmes began, the jury heard testimony Tuesday that Theranos Inc. altered a doc to point consumers that its experience had been validated by a big pharmaceutical agency.

Constance Cullen, an immunology skilled who helped lead examine enchancment at pharmaceutical company Schering-Plough Corp. , testified that she had been unimpressed with Theranos and positioned Ms. Holmes “cagey” all through her strategy of evaluating the startup’s experience for a doable partnership. No matter that, prosecutors say, Theranos put Schering-Plough’s emblem on a doc it later gave to a possible enterprise affiliate and investor, purporting that the pharmaceutical agency had checked out and validated its blood-testing items.